UArizona COVID-19 Treatment Takes Next Step Toward Public Impact via License to Pharmaceutical Company

An image of the COVID-19 virus.
Tuesday, February 28, 2023

A compound developed by researchers at the R. Ken Coit College of Pharmacy moves one step closer to commercialization with new licensing agreement.

healthsciences.arizona.edu

Tags

COVID-19 vaccine
COVID-19

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now